Zuplenz soluble film approved in the US
This article was originally published in Scrip
Executive Summary
The US FDA has approved Strativa Pharmaceuticals' Zuplenz (ondansetron) oral-soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced and radiotherapy-induced nausea and vomiting.